NEW YORK--(BUSINESS WIRE)--ENB Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on oncology and immunology, today announced top-line results from the dual combination arm of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results